Canopy Growth Germany & dk Life Science Communications join forces for more trust in medicinal cannabis

Account win for dk Life Science Communications: The Frankfurt-based healthcare agency has been working closely with Canopy Growth, one of the leading providers of medicinal cannabis, since early 2024. dk is supporting the Canadian company in the strategic alignment and communication of the Canopy Medical brand in the German market.

‘We are delighted to have gained Canopy as a client that wants to promote medicinal cannabis as a serious form of therapy,’ states Dr Andreas Kloevekorn, Managing Director at dk. ‘This is an exciting and responsible taskthat our team is tackling with great commitment.’ 

Canopy Medical is one of the market-leading brands in the production, import and supply of medicinal cannabis products in Germany. The company aims at sustainably improving the quality of life of patients with high levels of suffering through the targeted use of cannabis. The focus lies primarily on the transfer of knowledge and education on treatment with medicinal cannabis.

‘It was important for us to have an experienced partner at our side to help us build a trustworthy relationship with key stakeholders, particularly within the HCP audience and among medical experts,’ explains Matthias Glaser, Managing Director at Canopy Growth Germany. ‘We expect both strategic advice and excellent operational implementation – which is why we chose dk.’

About dk Life Science Communications 

dk Life Science Communications has been one of the leading German communications agencies in the healthcare sector for over 30 years and is based in Frankfurt. The agency has been part of the WEFRA LIFE Group since 2023.

Media contact: 

Dr Andreas Kloevekorn
Management Board
dk Life Science Communications GmbH
Falkstraße 5
60487 Frankfurt am Main
Tel: +49 69 61998-0
Fax: +49 69 61998-10
dkcommunications.de